ESR1 and breast carcinoma: Cellular data demonstrated that all these compounds, SCR-6139, SCR-6515 and SCR-6852 effectively induce ERα degradation in MCF7 breast cancer cells (ERα wild-​type, wt), as shown in (Fig. 2a, Table 2, Additional file 1: Fig.S3).